These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1734 related items for PubMed ID: 18330088

  • 1. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [Abstract] [Full Text] [Related]

  • 2. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 3. 18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients.
    Saif MW, Cornfeld D, Modarresifar H, Ojha B.
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):173-8. PubMed ID: 18568138
    [Abstract] [Full Text] [Related]

  • 4. [Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
    Strunk H, Bucerius J, Jaeger U, Joe A, Flacke S, Reinhardt M, Hortling N, Palmedo H.
    Rofo; 2005 Sep; 177(9):1235-41. PubMed ID: 16123869
    [Abstract] [Full Text] [Related]

  • 5. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 6. PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
    Farma JM, Santillan AA, Melis M, Walters J, Belinc D, Chen DT, Eikman EA, Malafa M.
    Ann Surg Oncol; 2008 Sep; 15(9):2465-71. PubMed ID: 18551347
    [Abstract] [Full Text] [Related]

  • 7. Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.
    Buchs NC, Bühler L, Bucher P, Willi JP, Frossard JL, Roth AD, Addeo P, Rosset A, Terraz S, Becker CD, Ratib O, Morel P.
    J Gastroenterol Hepatol; 2011 Apr; 26(4):657-62. PubMed ID: 21155879
    [Abstract] [Full Text] [Related]

  • 8. Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience.
    Sharma P, Jain TK, Singh H, Suman SK, Faizi NA, Kumar R, Bal C, Malhotra A, Kumar R.
    Nucl Med Commun; 2013 Mar; 34(3):211-9. PubMed ID: 23353886
    [Abstract] [Full Text] [Related]

  • 9. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
    Deleau C, Buecher B, Rousseau C, Kraeber-Bodéré F, Flamant M, des Varannes SB, Frampas E, Galmiche JP, Matysiak-Budnik T.
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
    [Abstract] [Full Text] [Related]

  • 10. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [Abstract] [Full Text] [Related]

  • 11. (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
    Al-Ibraheem A, Buck AK, Benz MR, Rudert M, Beer AJ, Mansour A, Pomykala KL, Haller B, Juenger H, Scheidhauer K, Schwaiger M, Herrmann K.
    Cancer; 2013 Mar 15; 119(6):1227-34. PubMed ID: 23233156
    [Abstract] [Full Text] [Related]

  • 12. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT, Hu C, Chiu YL, Peng NJ, Liu RS.
    PLoS One; 2014 Mar 15; 9(12):e115127. PubMed ID: 25517451
    [Abstract] [Full Text] [Related]

  • 13. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H, Henderson RW, Conti PS.
    J Comput Assist Tomogr; 2007 Mar 15; 31(2):223-8. PubMed ID: 17414758
    [Abstract] [Full Text] [Related]

  • 14. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF, Liu Y, Zhang JH, Zhou RS, Zhou FH, Yuan MH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb 15; 28(2):108-11. PubMed ID: 15854393
    [Abstract] [Full Text] [Related]

  • 15. Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: comparison with PET and enhanced CT.
    Dirisamer A, Halpern BS, Flöry D, Wolf F, Beheshti M, Mayerhoefer ME, Langsteger W.
    Eur J Radiol; 2010 Feb 15; 73(2):324-8. PubMed ID: 19200683
    [Abstract] [Full Text] [Related]

  • 16. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
    Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, Werbrouck P.
    Eur Urol; 2010 Apr 15; 57(4):641-7. PubMed ID: 19477579
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.
    Nakajo M, Nakajo M, Jinguji M, Tani A, Kajiya Y, Tanabe H, Fukukura Y, Nakabeppu Y, Koriyama C.
    Radiology; 2013 Jun 15; 267(3):891-901. PubMed ID: 23468571
    [Abstract] [Full Text] [Related]

  • 18. Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19-9 levels in detecting recurrent pancreatic adenocarcinoma.
    Hamidian Jahromi A, Sangster G, Zibari G, Martin B, Chu Q, Takalkar A, Shi R, Shokouh-Amiri H.
    JOP; 2013 Jul 11; 14(4):466-8. PubMed ID: 23846950
    [Abstract] [Full Text] [Related]

  • 19. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.
    Eur J Cardiothorac Surg; 2009 Sep 11; 36(3):440-5. PubMed ID: 19464906
    [Abstract] [Full Text] [Related]

  • 20. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
    Tuncel M, Souvatzoglou M, Herrmann K, Stollfuss J, Schuster T, Weirich G, Wester HJ, Schwaiger M, Krause BJ.
    Nucl Med Biol; 2008 Aug 11; 35(6):689-95. PubMed ID: 18678354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 87.